Showing results (1951-1960 of 2,002) with videos related to
Sort By:
Pageof 201
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.BMC Geriatrics|April 22, 2017
Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countriesSven Streit, Marjolein Verschoor, Nicolas Rodondi, et al.Scandinavian Journal of Primary Health Care|January 26, 2018
Burden of cardiovascular disease across 29 countries and GPs' decision to treat hypertension in oldest-oldSven Streit, Jacobijn Gussekloo, Robert A Burman, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.Journal of General Internal Medicine|January 18, 2019
Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 CountriesMilly A van der Ploeg, Sven Streit, Wilco P Achterberg, et al.BMC Geriatrics|January 8, 2021
General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countriesKatharina Tabea Jungo, Sophie Mantelli, Zsofia Rozsnyai, et al.ACS Nano|May 30, 2024
Nanocrystal Assemblies: Current Advances and Open ProblemsCarlos L Bassani, Greg van Anders, Uri Banin, et al.Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.Pageof 201